stoxline Quote Chart Rank Option Currency Glossary
  
Oaktree Acquisition Corp. III Life Sciences (OACC)
10.67  0.02 (0.19%)    06-17 12:59
Open: 10.65
High: 10.67
Volume: 2,162
  
Pre. Close: 10.65
Low: 10.65
Market Cap: 262(M)
Technical analysis
2026-06-17 12:46:47 PM
Short term     
Mid term     
Targets 6-month :  12.5 1-year :  12.55
Resists First :  10.7 Second :  10.75
Pivot price 10.66
Supports First :  10.64 Second :  8.85
MAs MA(5) :  10.68 MA(20) :  10.67
MA(100) :  10.65 MA(250) :  10.57
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  39.3 D(3) :  62.2
RSI RSI(14): 46.6
52-week High :  10.75 Low :  10.3
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ OACC ] has closed above bottom band by 33.3%. Bollinger Bands are 18.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 10.66 - 10.72 10.72 - 10.77
Low: 10.51 - 10.58 10.58 - 10.63
Close: 10.54 - 10.65 10.65 - 10.75
Company Description

Oaktree Acquisition Corp. III Life Sciences is dedicated to completing a strategic business combination, such as a merger, asset acquisition, share purchase, reorganization, or similar transaction, with one or more companies. The firm's focus is on identifying and acquiring entities within the biopharmaceutical, medical device, diagnostics, and specialized healthcare services industries located across North America and Europe. This company was formed in 2024 and is headquartered in Los Angeles, California.

Headline News

Tue, 16 Jun 2026
Fox Corp. Acquires Roku in $22 Billion Streaming Power Play - Gross Profit Margin - newsline.com

Sun, 07 Jun 2026
Oaktree Acquisition Corp. III Life Sciences (OACC) Holds Steady at $10.65 Amid SPAC Trading Patterns - Revenue Weighted - newsline.com

Wed, 27 May 2026
Oaktree Acquisition Corp. III Life Sciences (OACC) Holds Steady at $10.69 – SPAC Stability in Focus - Reversal Setup Alerts - newsline.com

Fri, 22 May 2026
Oaktree Acquisition Corp. III Life Sciences (OACC) Holds Steady Near $10.70 as SPAC Investors Await Transaction Announcement - Change of Character - newsline.com

Sun, 17 May 2026
Oaktree SPAC draws trader attention after 5% filing - Bez Kabli

Wed, 08 Apr 2026
Is Arcelor (MT) Stock breaking key levels | Price at $53.80, Up 0.86% - Buyback Factor - newsline.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Financial Services
Industry:
Shell Companies
Shares Out 20 (M)
Shares Float 18 (M)
Held by Insiders 0 (%)
Held by Institutions 90.6 (%)
Shares Short 27 (K)
Shares Short P.Month 27 (K)
Stock Financials
EPS 0.28
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.29
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -16 %
Operating Cash Flow -1 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 36.72
PEG Ratio 0
Price to Book value -36.73
Price to Sales 0
Price to Cash Flow -417.52
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android